BioCentury
ARTICLE | Financial News

Alpine BioVentures financial update

September 9, 2013 7:00 AM UTC

Mitchell Gold, former president and CEO of immunotherapy cancer company Dendreon Corp. (NASDAQ:DNDN, Seattle, Wash.), and biotech analyst David Miller launched biotech hedge fund Alpine BioVentures. ...